Consider this post the context-setting for the 2026 Health Populi TrendCast which youll see next week
Currently, there is little to no research on how GLP-1 medication impacts other eating disorders
Tirzepatide 15 mg was also associated with higher incidence of vomiting (OR 5.50 [95% CI 2.40, 12.59], I 2 0%) and diarrhoea (OR 3.31 [95% CI 1.40, 7.85], I 2 52%), while more participants receiving tirzepatide 10 mg experienced vomiting (OR 2.98 [95% CI 1.13, 7.80], I 2 0%) (Table 2)
If you have any joint problems, heart conditions, or have been sedentary for several years, a brief check-in with your doctor before starting is wise
doi:10.1111/acem.70088
Since side effects are often linked to dose strength, starting on a lower dose helps the body adjust and can reduce their impact